User contributions
Jump to navigation
Jump to search
- 00:19, 19 March 2024 diff hist +4 m Study Groups →Main table current
- 20:48, 17 March 2024 diff hist +14 m Non-small cell lung cancer - historical →VIP {{#subobject:e6f7b9|Regimen=1}} current
- 20:45, 17 March 2024 diff hist 0 m Gastric cancer →UFT monotherapy {{#subobject:ecufef|Regimen=1}} current
- 20:16, 17 March 2024 diff hist +10 m Myelofibrosis →Lenalidomide monotherapy {{#subobject:1 |Regimen=1}} current
- 18:30, 17 March 2024 diff hist +62 m Allogeneic HSCT current
- 18:29, 17 March 2024 diff hist -3 m Renal cell carcinoma - historical current
- 18:29, 17 March 2024 diff hist -3 m Chronic lymphocytic leukemia current
- 17:43, 17 March 2024 diff hist +45 m Clear cell renal cell carcinoma →Belzutifan monotherapy {{#subobject:anc684|Regimen=1}} current
- 00:53, 15 March 2024 diff hist -1 m Breast cancer, HER2-positive →Targeted therapy current
- 21:01, 14 March 2024 diff hist +13 m Melanoma, BRAF-mutated →Immunotherapy current
- 02:04, 14 March 2024 diff hist -17 m Mantle cell lymphoma →R-Hyper-CVAD/R-MA {{#subobject:a76238|Regimen=1}} current
- 01:38, 14 March 2024 diff hist +3,382 m Gastric cancer →Docetaxel & S-1 {{#subobject:a22c2a|Regimen=1}}
- 01:11, 14 March 2024 diff hist +2 m Breast cancer - historical →Chemotherapy, CMF portion (cycles 2, 4, 6, 8, 10, 12 current
- 00:31, 13 March 2024 diff hist +146 m Small cell lung cancer current
- 20:07, 12 March 2024 diff hist -1 m Chronic lymphocytic leukemia →Targeted therapy
- 13:53, 12 March 2024 diff hist +131 m Breast cancer, HER2-positive →THP (Docetaxel) {{#subobject:24b376|Regimen=1}}
- 13:51, 12 March 2024 diff hist +1,359 m Breast cancer, HER2-positive →References
- 13:50, 12 March 2024 diff hist +780 m Breast cancer, HER2-positive
- 13:09, 12 March 2024 diff hist +39 m Mantle cell lymphoma →R-Hyper-CVAD/R-MA {{#subobject:a76238|Regimen=1}}
- 13:06, 12 March 2024 diff hist +2 m Multiple myeloma, induction →Glucocorticoid therapy current
- 13:05, 12 March 2024 diff hist 0 m Breast cancer, HER2-positive
- 13:04, 12 March 2024 diff hist +1 m Classical Hodgkin lymphoma →Chemotherapy current
- 12:43, 12 March 2024 diff hist -10 m Chronic lymphocytic leukemia →Targeted therapy
- 16:52, 11 March 2024 diff hist +3,387 m Urothelial carcinoma current
- 01:00, 11 March 2024 diff hist -552 m Light-chain (AL) amyloidosis →Bortezomib & Melphalan, then auto HSCT {{#subobject:5426f4|Regimen=1}} current
- 00:59, 10 March 2024 diff hist +17 m Breast cancer, HER2-positive →Targeted therapy, TL portion (cycles 5 to 8)
- 03:04, 9 March 2024 diff hist -329 m CNS lymphoma →Bu/TT/Cy, then auto HSCT {{#subobject:e04a91|Regimen=1}} current
- 03:04, 9 March 2024 diff hist -232 m CNS lymphoma →Bu/TT, then auto HSCT {{#subobject:e04a91|Regimen=1}}
- 03:03, 9 March 2024 diff hist +1 m Autologous HSCT →Bu/TT/Cy {{#subobject:e04a91|Regimen=1}} current
- 03:02, 9 March 2024 diff hist -947 m CNS lymphoma →BEAM, then auto HSCT {{#subobject:c9216e|Regimen=1}}
- 03:00, 9 March 2024 diff hist -757 m CNS lymphoma →BCNU/TT, then auto HSCT {{#subobject:a7b7ae|Regimen=1}}
- 01:24, 9 March 2024 diff hist +32 m Breast cancer, ER-positive current
- 22:38, 8 March 2024 diff hist +53 m Inotuzumab ozogamicin (Besponsa) current
- 22:26, 8 March 2024 diff hist +123 m Inotuzumab ozogamicin (Besponsa) →History of changes in FDA indication
- 20:05, 8 March 2024 diff hist 0 m Urothelial carcinoma
- 20:04, 8 March 2024 diff hist 0 m Soft tissue sarcoma current
- 20:03, 8 March 2024 diff hist 0 m Small cell lung cancer
- 20:03, 8 March 2024 diff hist 0 m Small cell lung cancer - null regimens current
- 20:03, 8 March 2024 diff hist 0 m Renal cell carcinoma current
- 20:02, 8 March 2024 diff hist 0 m Renal cell carcinoma - null regimens current
- 20:01, 8 March 2024 diff hist 0 m Rectal cancer - null regimens current
- 20:01, 8 March 2024 diff hist 0 m Non-small cell lung cancer - historical
- 20:00, 8 March 2024 diff hist 0 m Non-small cell lung cancer - null regimens current
- 20:00, 8 March 2024 diff hist 0 m Neuroendocrine tumor current
- 19:59, 8 March 2024 diff hist +19 m Hepatocellular carcinoma current
- 19:58, 8 March 2024 diff hist 0 m Hepatocellular carcinoma - null regimens current
- 19:57, 8 March 2024 diff hist 0 m Diffuse large B-cell lymphoma current
- 19:57, 8 March 2024 diff hist 0 m Diffuse large B-cell lymphoma - null regimens current
- 19:56, 8 March 2024 diff hist 0 m Acute myeloid leukemia current
- 19:55, 8 March 2024 diff hist 0 m Acute myeloid leukemia - null regimens current